Local delivery of anti–TNF-α neutralizing antibody rescues the pro-metastatic effects of β-catenin activation in AMs, and TNF correlates with CTNNB1 expression in the AMs of cancer patients. The gene discussed is CTNNB1; the disease is cancer.